Tech Company Financing Transactions
Excaliard Pharmaceuticals Funding Round
Excaliard Pharmaceuticals, operating out of Carlsbad, secured $15.5 million from Alta Partners, ProQuest Investments and RiverVest Venture Partners.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$15,499,900
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2141 Palomar Airport Road 300
Carlsbad, CA 92011
USA
Carlsbad, CA 92011
USA
Phone
Website
Email Address
Overview
The company develops therapeutics for the treatment of scarring and fibrotic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Ian Wisenberg
Chief Medical Officer
Gary Gentzkow
Chief Scientific Officer
Nicholas Dean
President
Gordon Foulkes
VP - Operations
Jeff Jensen
VP - Regulatory Affairs
Elizabeth Gordon
Browse more venture capital transactions:
Prev: 12/31/2007: Resource Energy Systems Technologies venture capital transaction
Next: 12/31/2007: Sierra Neuropharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs